Clinical trial

Clinical Study on the Immunomodulatory Effect of Eprolidone on Patients With Chronic Heart Failure

NCT05924958

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Eprolidone Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Clinical Study on the Immunomodulatory Effect of Eprolidone on Patients With Chronic Heart Failure

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: EARLY_PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2023-09-01

PhaseEARLY_PHASE1

Conditions

Chronic Heart Failure Patientsunresolved

Interventions

EprolidoneDRUG

Sponsors & collaborators

Cheng LuFeng,Principal Investigatorlead sponsor

First Affiliated Hospital of Xinjiang Medical Universitycollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05924958 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.